Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Follicular × Methylprednisolone × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Down Syndrome 1 Brain Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Rituximab 15 Cyclophosphamide 14 Lenalidomide 12 Prednisone 9 Vincristine 8 Doxorubicin 8 obinutuzumab 5 fludarabine 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 R-CHOP protocol 4 Biopsy 4 Bendamustine Hydrochloride 4 zanubrutinib 3 ibrutinib 3 fludarabine phosphate 3 tisagenlecleucel 2 tazemetostat 2 Whole-Body Irradiation 2 Temozolomide 2 Radiotherapy 2 Prednisolone 2 Oxaliplatin 2 Gemcitabine 2 Cyclosporine 2 CT-P10 2 voruciclib 1 venetoclax 1 umbralisib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06091254 2026-03-11

OLYMPIA-1

Regeneron Pharmaceuticals

Phase 3 Recruiting

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡